Dealmoney Commodities Revises Disclosure for ₹180 Crore Warrant Acquisition in Family Care Hospitals

1 min read     Updated on 21 Jan 2026, 01:44 PM
scanx
Reviewed by
Jubin VScanX News Team
Overview

Dealmoney Commodities Private Limited has submitted a revised disclosure correcting the diluted share capital figure in its warrant acquisition of Family Care Hospitals Limited. The company acquired 1.80 crore warrants for ₹180 crores through preferential allotment, representing a 24.76% stake. The corrected disclosure shows Family Care Hospitals' diluted share capital at 72.69 crore equity shares.

30528889

*this image is generated using AI for illustrative purposes only.

Dealmoney Commodities Private Limited has filed a revised regulatory disclosure to correct an inadvertent error in previously submitted documentation regarding its warrant acquisition in Family Care Hospitals Limited. The correction pertains to the diluted paid-up share capital figure disclosed under SEBI's substantial acquisition regulations.

Transaction Details

The warrant acquisition transaction involves significant financial parameters that demonstrate Dealmoney's strategic investment in the healthcare sector:

Parameter Details
Warrants Acquired 1,80,00,000
Acquisition Value ₹180.00 crores
Stake Percentage 24.76%
Acquisition Mode Preferential allotment
Transaction Date December 26, 2025

Share Capital Structure

The revised disclosure clarifies Family Care Hospitals' capital structure following the warrant allotment:

Capital Type Number of Shares Face Value
Current Equity Share Capital 54,01,47,774 ₹10.00 each
Total Diluted Share Capital 72,69,22,774 ₹10.00 each
Warrants Outstanding 1,80,00,000 ₹10.00 each

Regulatory Compliance

The original disclosure was submitted on December 29, 2025, under Regulation 29(1) of SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011. Dealmoney identified the error in the diluted share capital figure and promptly filed the corrected version on January 21, 2026. The company belongs to the promoter group of Family Care Hospitals Limited, which is listed on BSE Limited under scrip code 516110.

Shareholding Position

Prior to this acquisition, Dealmoney held no shares, voting rights, or convertible instruments in Family Care Hospitals. The warrant acquisition represents the company's first substantial investment in the target company. Post-acquisition, Dealmoney's total holding stands at 1.80 crore warrants, representing 24.76% of both the total share capital and diluted voting capital.

Corporate Information

Dealmoney Commodities Private Limited operates from its registered office in Thane, Maharashtra. The revised disclosure was signed by Director Anil R Bapardekar (DIN: 10126442), emphasizing the company's commitment to accurate regulatory reporting and transparency in substantial acquisition transactions.

Historical Stock Returns for Family Care Hospitals

1 Day5 Days1 Month6 Months1 Year5 Years
-2.01%-3.93%-7.32%-21.38%-48.42%-72.20%
Family Care Hospitals
View in Depthredirect
like18
dislike

Family Care Hospitals Reports Q3 FY26 Results, Recommends Director Reappointments

3 min read     Updated on 20 Jan 2026, 08:03 PM
scanx
Reviewed by
Shriram SScanX News Team
Overview

Family Care Hospitals Limited reported Q3 FY26 results with revenue of ₹6.01 lakhs and net loss of ₹95.74 lakhs for the quarter ended December 31, 2025. The company's nine-month revenue declined significantly to ₹15.11 lakhs from ₹788.03 lakhs in the previous year. The Board recommended reappointment of three directors for second terms and approved a postal ballot process for shareholder approval. The company received ₹4.67 crores from share warrant allotments during the quarter.

30465214

*this image is generated using AI for illustrative purposes only.

Family Care Hospitals Limited announced its unaudited financial results for the third quarter ended December 31, 2025, along with significant board developments and corporate governance decisions. The Board of Directors convened on January 20, 2026, to approve the quarterly results and several key appointments.

Financial Performance Overview

The company's financial performance for Q3 FY26 showed challenging operational metrics across key parameters:

Financial Metric Q3 FY26 Q3 FY25 Nine Months FY26 Nine Months FY25
Revenue from Operations ₹6.01 lakhs ₹2.83 lakhs ₹15.11 lakhs ₹788.03 lakhs
Other Income ₹2.81 lakhs ₹0.04 lakhs ₹13.22 lakhs ₹112.46 lakhs
Total Income ₹8.82 lakhs ₹2.87 lakhs ₹28.34 lakhs ₹900.48 lakhs
Net Loss ₹95.74 lakhs ₹209.59 lakhs ₹625.98 lakhs ₹4,513.59 lakhs
Basic EPS ₹(0.18) ₹(0.39) ₹(1.16) ₹(8.36)

The company's total expenses for Q3 FY26 amounted to ₹104.56 lakhs, resulting in a loss before tax of ₹95.74 lakhs. Major expense components included other expenses of ₹56.30 lakhs, depreciation of ₹22.20 lakhs, and employee benefits expense of ₹12.61 lakhs.

Board Recommendations and Director Appointments

The Nomination and Remuneration Committee and Board of Directors have recommended several key appointments for second terms:

Independent Director Reappointments

Director Details Appointment Information
Mrs. Archana Chirawawala Non-Executive Independent Director
DIN 09721625
Effective Date February 28, 2026
Term Duration 5 years (second term)
Professional Background Chartered Accountant with 20+ years experience
Director Details Appointment Information
Mr. Sanjeev Seth Non-Executive Independent Director
DIN 10974972
Effective Date February 28, 2026
Term Duration 5 years (second term)
Professional Background 33 years industry experience, 16 years in sales, 17 years in marketing

Executive Director Reappointment

Director Details Appointment Information
Mr. Suchit Raghunath Modshing Executive Whole Time Director
DIN 10974977
Effective Date February 28, 2026
Term Duration 5 years (second term)
Professional Background 12+ years administrative experience, Bachelor of Commerce

All three directors are not related to any existing Directors or Key Managerial Personnel of the company, and their appointments are subject to shareholder approval.

Corporate Governance and Postal Ballot Process

The Board has initiated a comprehensive postal ballot process to seek shareholder approval for the director appointments. Key decisions include:

  • Postal Ballot Notice: Finalized and approved by the Board
  • Scrutinizer Appointment: M/s. Mukesh Siroya and Co. Practicing Company Secretary
  • E-voting Agency: Purva Sharegistry (India) Private Limited
  • Cut-off Date: January 16, 2025, for determining eligible voting members

Share Warrant Allotment

During the quarter, Family Care Hospitals received ₹4.67 crores from the preferential allotment of 18,677,500 share warrants. This includes ₹4.50 crores from Dealmoney Commodities Private Limited, representing 25% of the issue price. The allotment was conducted pursuant to SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, with the balance amount to be received upon warrant exercise.

Operational Context

The company operates exclusively in the healthcare services segment, with a paid-up equity share capital of ₹5,401.48 lakhs. The financial results were reviewed by the Audit Committee and approved by the Board of Directors, with statutory auditor review completed by Rafik and Associates, Chartered Accountants. The Board meeting commenced at 3:50 PM and concluded at 6:30 PM on January 20, 2026.

Historical Stock Returns for Family Care Hospitals

1 Day5 Days1 Month6 Months1 Year5 Years
-2.01%-3.93%-7.32%-21.38%-48.42%-72.20%
Family Care Hospitals
View in Depthredirect
like20
dislike
More News on Family Care Hospitals
Explore Other Articles
3.42
-0.07
(-2.01%)